Have a personal or library account? Click to login
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm Cover

Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm

Tremor and Other Hyperkinetic Movements
Volume 4 (2014): Issue 0
By: Hubert H. Fernandez,  Joseph Jankovic,  John B. Holds,  Daniel Lin,  John Burns,  Amit Verma,  Kapil Sethi,  Eric J. Pappert and  on behalf of the XCiDaBLE Study Group  
Open Access
|Jul 2014

References

  1. 1
    TsuiJKBlepharospasm and hemifacial spasmBrinMFJankovicJComellaCLDystonia: Etiology, clinical features, and treatmentPhiladelphiaLippincott Williams and Wilkins2004151157
    Back to article
  2. 2
    McCannJDSaulnySGolbergRAAndersenRLEssential blepharospasmChenWPOculoplastic surgery: The essentialsNew YorkThieme New York2001113124
    Back to article
  3. 3
    TarsyDSimonDKDystoniaN Engl J Med200635581882916928997
    Back to article
  4. 4
    SimpsonDMBlitzerABrashearAet alAssessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyNeurology2008701699170618458230
    Back to article
  5. 5
    JankovicJComellaCHanschmannAet alEfficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm – a randomized trialMov Disord2011261521152821520284
    Back to article
  6. 6
    WabbelsBReichelGFulford-SmithAet alDouble-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasmJ Neural Transm201111823323921161715
    Back to article
  7. 7
    TruongDDGollompSMJankovicJet alXeomin US Blepharospasm Study Group. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasmJ Neural Transm20131201345135323435927
    Back to article
  8. 8
    ColosimoCTipleDBerardelliAEfficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: A systematic reviewNeurotox Res20122226527322359151
    Back to article
  9. 9
    BarashJRArnonSSA novel strain of Clostridium botulinum that produces type B and type H botulinum toxinsJ Infect Dis201420918319124106296
    Back to article
  10. 10
    FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasmhttp://www.drugs.com/newdrugs/fda-approves-merz-pharmaceuticals-xeomin-incobotulinumtoxina-cervical-dystonia-blepharospasm-2233.html. Accessed March 21, 2014
    Back to article
  11. 11
    RoggenkamperPJostWHBihariKet alEfficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasmJ Neural Transm200611330331215959841
    Back to article
  12. 12
    FernandezHHPaganFDanisiFet alXCiDaBLE Study Group. Prospective study evaluating incobotulinumtoxinA for cervical dystonia or blepharospasm: Interim results from the first 145 subjects with cervical dystoniaTremor Other Hyperkinet Mov201317113
    Back to article
  13. 13
    JankovicJKenneyCGrafeSet alRelationship between various clinical outcome assessments in patients with blepharospasmMov Disord20092440741319053054
    Back to article
  14. 14
    Quality MetricSF-12v2 Health Surveyshttp://www.qualitymetric.com/WhatWeDo/GenericHealthSurveys/SF12v2HealthSurvey/tabid/186/Default.aspx. Accessed March 21, 2014
    Back to article
  15. 15
    ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics1993435336510146874
    Back to article
  16. 16
    PaganFLHarrisonAA guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin®: A new botulinum neurotoxin AParkinsonism Relat Disord20121844144522405829
    Back to article
DOI: https://doi.org/10.5334/tohm.181 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Apr 4, 2014
Accepted on: Jun 18, 2014
Published on: Jul 16, 2014
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Open label,
prospective,
blepharospasm,
incobotulinumtoxinA,
Jankovic Rating Scale,
Xeomin

© 2014 Hubert H. Fernandez, Joseph Jankovic, John B. Holds, Daniel Lin, John Burns, Amit Verma, Kapil Sethi, Eric J. Pappert, on behalf of the XCiDaBLE Study Group, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 4 (2014): Issue 0Next article